Global Seasonal Influenza Vaccines Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Seasonal Influenza Vaccines Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
The Global Info Research report includes an overview of the development of the Seasonal Influenza Vaccines Therapeutics industry chain, the market status of Hospitals (Paediatrics, Adolescence), Clinics (Paediatrics, Adolescence), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Seasonal Influenza Vaccines Therapeutics.
Regionally, the report analyzes the Seasonal Influenza Vaccines Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Seasonal Influenza Vaccines Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Seasonal Influenza Vaccines Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Seasonal Influenza Vaccines Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Paediatrics, Adolescence).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Seasonal Influenza Vaccines Therapeutics market.
Regional Analysis: The report involves examining the Seasonal Influenza Vaccines Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Seasonal Influenza Vaccines Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Seasonal Influenza Vaccines Therapeutics:
Company Analysis: Report covers individual Seasonal Influenza Vaccines Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Seasonal Influenza Vaccines Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Seasonal Influenza Vaccines Therapeutics. It assesses the current state, advancements, and potential future developments in Seasonal Influenza Vaccines Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Seasonal Influenza Vaccines Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Seasonal Influenza Vaccines Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Seasonal Influenza Vaccines Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Seasonal Influenza Vaccines Therapeutics, with revenue, gross margin and global market share of Seasonal Influenza Vaccines Therapeutics from 2019 to 2024.
Chapter 3, the Seasonal Influenza Vaccines Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Seasonal Influenza Vaccines Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Influenza Vaccines Therapeutics.
Chapter 13, to describe Seasonal Influenza Vaccines Therapeutics research findings and conclusion.
Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
The Global Info Research report includes an overview of the development of the Seasonal Influenza Vaccines Therapeutics industry chain, the market status of Hospitals (Paediatrics, Adolescence), Clinics (Paediatrics, Adolescence), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Seasonal Influenza Vaccines Therapeutics.
Regionally, the report analyzes the Seasonal Influenza Vaccines Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Seasonal Influenza Vaccines Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Seasonal Influenza Vaccines Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Seasonal Influenza Vaccines Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Paediatrics, Adolescence).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Seasonal Influenza Vaccines Therapeutics market.
Regional Analysis: The report involves examining the Seasonal Influenza Vaccines Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Seasonal Influenza Vaccines Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Seasonal Influenza Vaccines Therapeutics:
Company Analysis: Report covers individual Seasonal Influenza Vaccines Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Seasonal Influenza Vaccines Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Seasonal Influenza Vaccines Therapeutics. It assesses the current state, advancements, and potential future developments in Seasonal Influenza Vaccines Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Seasonal Influenza Vaccines Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Seasonal Influenza Vaccines Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Paediatrics
- Adolescence
- Adults
- Elderly
- Hospitals
- Clinics
- Others
- GSK
- Novartis
- CSL
- MedImmune
- Sanofi-Pasteur
- Solvay
- Hualan Biological Engineering
- Sinovac Biotech
- Changchun Institute of Biological Products Co., Ltd.
- Shanghai Institute of Biological Products Co., Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Seasonal Influenza Vaccines Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Seasonal Influenza Vaccines Therapeutics, with revenue, gross margin and global market share of Seasonal Influenza Vaccines Therapeutics from 2019 to 2024.
Chapter 3, the Seasonal Influenza Vaccines Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Seasonal Influenza Vaccines Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Influenza Vaccines Therapeutics.
Chapter 13, to describe Seasonal Influenza Vaccines Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Seasonal Influenza Vaccines Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Seasonal Influenza Vaccines Therapeutics by Type
1.3.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Paediatrics
1.3.4 Adolescence
1.3.5 Adults
1.3.6 Elderly
1.4 Global Seasonal Influenza Vaccines Therapeutics Market by Application
1.4.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size & Forecast
1.6 Global Seasonal Influenza Vaccines Therapeutics Market Size and Forecast by Region
1.6.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments and Future Plans
2.4 MedImmune
2.4.1 MedImmune Details
2.4.2 MedImmune Major Business
2.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MedImmune Recent Developments and Future Plans
2.5 Sanofi-Pasteur
2.5.1 Sanofi-Pasteur Details
2.5.2 Sanofi-Pasteur Major Business
2.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi-Pasteur Recent Developments and Future Plans
2.6 Solvay
2.6.1 Solvay Details
2.6.2 Solvay Major Business
2.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Solvay Recent Developments and Future Plans
2.7 Hualan Biological Engineering
2.7.1 Hualan Biological Engineering Details
2.7.2 Hualan Biological Engineering Major Business
2.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.7.4 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Biological Engineering Recent Developments and Future Plans
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.8.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Biotech Recent Developments and Future Plans
2.9 Changchun Institute of Biological Products Co., Ltd.
2.9.1 Changchun Institute of Biological Products Co., Ltd. Details
2.9.2 Changchun Institute of Biological Products Co., Ltd. Major Business
2.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.9.4 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
2.10 Shanghai Institute of Biological Products Co., Ltd.
2.10.1 Shanghai Institute of Biological Products Co., Ltd. Details
2.10.2 Shanghai Institute of Biological Products Co., Ltd. Major Business
2.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.10.4 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Seasonal Influenza Vaccines Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Seasonal Influenza Vaccines Therapeutics by Company Revenue
3.2.2 Top 3 Seasonal Influenza Vaccines Therapeutics Players Market Share in 2023
3.2.3 Top 6 Seasonal Influenza Vaccines Therapeutics Players Market Share in 2023
3.3 Seasonal Influenza Vaccines Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Seasonal Influenza Vaccines Therapeutics Market: Region Footprint
3.3.2 Seasonal Influenza Vaccines Therapeutics Market: Company Product Type Footprint
3.3.3 Seasonal Influenza Vaccines Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.3.1 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Seasonal Influenza Vaccines Therapeutics Market Drivers
11.2 Seasonal Influenza Vaccines Therapeutics Market Restraints
11.3 Seasonal Influenza Vaccines Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Seasonal Influenza Vaccines Therapeutics Industry Chain
12.2 Seasonal Influenza Vaccines Therapeutics Upstream Analysis
12.3 Seasonal Influenza Vaccines Therapeutics Midstream Analysis
12.4 Seasonal Influenza Vaccines Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Seasonal Influenza Vaccines Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Seasonal Influenza Vaccines Therapeutics by Type
1.3.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Paediatrics
1.3.4 Adolescence
1.3.5 Adults
1.3.6 Elderly
1.4 Global Seasonal Influenza Vaccines Therapeutics Market by Application
1.4.1 Overview: Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size & Forecast
1.6 Global Seasonal Influenza Vaccines Therapeutics Market Size and Forecast by Region
1.6.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments and Future Plans
2.4 MedImmune
2.4.1 MedImmune Details
2.4.2 MedImmune Major Business
2.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MedImmune Recent Developments and Future Plans
2.5 Sanofi-Pasteur
2.5.1 Sanofi-Pasteur Details
2.5.2 Sanofi-Pasteur Major Business
2.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi-Pasteur Recent Developments and Future Plans
2.6 Solvay
2.6.1 Solvay Details
2.6.2 Solvay Major Business
2.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Solvay Recent Developments and Future Plans
2.7 Hualan Biological Engineering
2.7.1 Hualan Biological Engineering Details
2.7.2 Hualan Biological Engineering Major Business
2.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.7.4 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Biological Engineering Recent Developments and Future Plans
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.8.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sinovac Biotech Recent Developments and Future Plans
2.9 Changchun Institute of Biological Products Co., Ltd.
2.9.1 Changchun Institute of Biological Products Co., Ltd. Details
2.9.2 Changchun Institute of Biological Products Co., Ltd. Major Business
2.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.9.4 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
2.10 Shanghai Institute of Biological Products Co., Ltd.
2.10.1 Shanghai Institute of Biological Products Co., Ltd. Details
2.10.2 Shanghai Institute of Biological Products Co., Ltd. Major Business
2.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
2.10.4 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Seasonal Influenza Vaccines Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Seasonal Influenza Vaccines Therapeutics by Company Revenue
3.2.2 Top 3 Seasonal Influenza Vaccines Therapeutics Players Market Share in 2023
3.2.3 Top 6 Seasonal Influenza Vaccines Therapeutics Players Market Share in 2023
3.3 Seasonal Influenza Vaccines Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Seasonal Influenza Vaccines Therapeutics Market: Region Footprint
3.3.2 Seasonal Influenza Vaccines Therapeutics Market: Company Product Type Footprint
3.3.3 Seasonal Influenza Vaccines Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Seasonal Influenza Vaccines Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region
8.3.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Seasonal Influenza Vaccines Therapeutics Market Size by Country
9.3.1 South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.3.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Seasonal Influenza Vaccines Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Seasonal Influenza Vaccines Therapeutics Market Drivers
11.2 Seasonal Influenza Vaccines Therapeutics Market Restraints
11.3 Seasonal Influenza Vaccines Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Seasonal Influenza Vaccines Therapeutics Industry Chain
12.2 Seasonal Influenza Vaccines Therapeutics Upstream Analysis
12.3 Seasonal Influenza Vaccines Therapeutics Midstream Analysis
12.4 Seasonal Influenza Vaccines Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 8. GSK Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GSK Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 13. Novartis Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. CSL Company Information, Head Office, and Major Competitors
Table 16. CSL Major Business
Table 17. CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 18. CSL Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. CSL Recent Developments and Future Plans
Table 20. MedImmune Company Information, Head Office, and Major Competitors
Table 21. MedImmune Major Business
Table 22. MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 23. MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. MedImmune Recent Developments and Future Plans
Table 25. Sanofi-Pasteur Company Information, Head Office, and Major Competitors
Table 26. Sanofi-Pasteur Major Business
Table 27. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 28. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi-Pasteur Recent Developments and Future Plans
Table 30. Solvay Company Information, Head Office, and Major Competitors
Table 31. Solvay Major Business
Table 32. Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 33. Solvay Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Solvay Recent Developments and Future Plans
Table 35. Hualan Biological Engineering Company Information, Head Office, and Major Competitors
Table 36. Hualan Biological Engineering Major Business
Table 37. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 38. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hualan Biological Engineering Recent Developments and Future Plans
Table 40. Sinovac Biotech Company Information, Head Office, and Major Competitors
Table 41. Sinovac Biotech Major Business
Table 42. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 43. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sinovac Biotech Recent Developments and Future Plans
Table 45. Changchun Institute of Biological Products Co., Ltd. Company Information, Head Office, and Major Competitors
Table 46. Changchun Institute of Biological Products Co., Ltd. Major Business
Table 47. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 48. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Changchun Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
Table 50. Shanghai Institute of Biological Products Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Shanghai Institute of Biological Products Co., Ltd. Major Business
Table 52. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 53. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Shanghai Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
Table 55. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Seasonal Influenza Vaccines Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Seasonal Influenza Vaccines Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Seasonal Influenza Vaccines Therapeutics Players
Table 60. Seasonal Influenza Vaccines Therapeutics Market: Company Product Type Footprint
Table 61. Seasonal Influenza Vaccines Therapeutics Market: Company Product Application Footprint
Table 62. Seasonal Influenza Vaccines Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. Seasonal Influenza Vaccines Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Seasonal Influenza Vaccines Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Seasonal Influenza Vaccines Therapeutics Raw Material
Table 100. Key Suppliers of Seasonal Influenza Vaccines Therapeutics Raw Materials
Table 1. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. GSK Company Information, Head Office, and Major Competitors
Table 6. GSK Major Business
Table 7. GSK Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 8. GSK Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. GSK Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 13. Novartis Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. CSL Company Information, Head Office, and Major Competitors
Table 16. CSL Major Business
Table 17. CSL Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 18. CSL Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. CSL Recent Developments and Future Plans
Table 20. MedImmune Company Information, Head Office, and Major Competitors
Table 21. MedImmune Major Business
Table 22. MedImmune Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 23. MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. MedImmune Recent Developments and Future Plans
Table 25. Sanofi-Pasteur Company Information, Head Office, and Major Competitors
Table 26. Sanofi-Pasteur Major Business
Table 27. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 28. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi-Pasteur Recent Developments and Future Plans
Table 30. Solvay Company Information, Head Office, and Major Competitors
Table 31. Solvay Major Business
Table 32. Solvay Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 33. Solvay Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Solvay Recent Developments and Future Plans
Table 35. Hualan Biological Engineering Company Information, Head Office, and Major Competitors
Table 36. Hualan Biological Engineering Major Business
Table 37. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 38. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hualan Biological Engineering Recent Developments and Future Plans
Table 40. Sinovac Biotech Company Information, Head Office, and Major Competitors
Table 41. Sinovac Biotech Major Business
Table 42. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 43. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sinovac Biotech Recent Developments and Future Plans
Table 45. Changchun Institute of Biological Products Co., Ltd. Company Information, Head Office, and Major Competitors
Table 46. Changchun Institute of Biological Products Co., Ltd. Major Business
Table 47. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 48. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Changchun Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
Table 50. Shanghai Institute of Biological Products Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Shanghai Institute of Biological Products Co., Ltd. Major Business
Table 52. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product and Solutions
Table 53. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Shanghai Institute of Biological Products Co., Ltd. Recent Developments and Future Plans
Table 55. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Seasonal Influenza Vaccines Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Seasonal Influenza Vaccines Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Seasonal Influenza Vaccines Therapeutics Players
Table 60. Seasonal Influenza Vaccines Therapeutics Market: Company Product Type Footprint
Table 61. Seasonal Influenza Vaccines Therapeutics Market: Company Product Application Footprint
Table 62. Seasonal Influenza Vaccines Therapeutics New Market Entrants and Barriers to Market Entry
Table 63. Seasonal Influenza Vaccines Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Seasonal Influenza Vaccines Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Type (2019-2024)
Table 66. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024)
Table 68. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Seasonal Influenza Vaccines Therapeutics Raw Material
Table 100. Key Suppliers of Seasonal Influenza Vaccines Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Seasonal Influenza Vaccines Therapeutics Picture
Figure 2. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Paediatrics
Figure 5. Adolescence
Figure 6. Adults
Figure 7. Elderly
Figure 8. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Seasonal Influenza Vaccines Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players in 2023
Figure 24. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Seasonal Influenza Vaccines Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Seasonal Influenza Vaccines Therapeutics Market Share in 2023
Figure 27. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Seasonal Influenza Vaccines Therapeutics Market Drivers
Figure 66. Seasonal Influenza Vaccines Therapeutics Market Restraints
Figure 67. Seasonal Influenza Vaccines Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Seasonal Influenza Vaccines Therapeutics
Figure 71. Seasonal Influenza Vaccines Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Seasonal Influenza Vaccines Therapeutics Picture
Figure 2. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Paediatrics
Figure 5. Adolescence
Figure 6. Adults
Figure 7. Elderly
Figure 8. Global Seasonal Influenza Vaccines Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Seasonal Influenza Vaccines Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players in 2023
Figure 24. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Seasonal Influenza Vaccines Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Seasonal Influenza Vaccines Therapeutics Market Share in 2023
Figure 27. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Seasonal Influenza Vaccines Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Seasonal Influenza Vaccines Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Seasonal Influenza Vaccines Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Seasonal Influenza Vaccines Therapeutics Market Drivers
Figure 66. Seasonal Influenza Vaccines Therapeutics Market Restraints
Figure 67. Seasonal Influenza Vaccines Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccines Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Seasonal Influenza Vaccines Therapeutics
Figure 71. Seasonal Influenza Vaccines Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
